Linked Data API

Show Search Form

Search Results

1142430
star this property registered interest false more like this
star this property date less than 2019-07-25more like thismore than 2019-07-25
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading General Practitioners: Nurses more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what assessment they have made of pension provision for GP practice nurses and, in particular, the impact of their exclusion from the NHS pension scheme until 1997. more like this
star this property tabling member printed
Baroness Altmann more like this
star this property uin HL17504 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-07more like thismore than 2019-08-07
star this property answer text <p>Membership of the NHS Pension Scheme was extended to general practitioner (GP) practice nurses from September 1997, following an agreement reached with organisations representing nurses and GPs. Prior to this date, GP practice nurses were excluded because eligibility was originally limited to those directly employed by a National Health Service body. GP practice nurses are employed directly by self-employed GPs, rather than the NHS.</p><p>The pressure on NHS Pension Scheme costs, which are met mutually across all members and their employers, meant that practice nurses could not be offered retrospective membership for employment before 1997. This was accepted by staff representatives at the time of the agreement, and remains the current position.</p><p>However, GP practice nurses and their employers can make voluntary extra contributions to purchase units of ‘Additional Pension’ and so boost their NHS retirement pensions.</p> more like this
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-08-07T11:43:50.453Zmore like thismore than 2019-08-07T11:43:50.453Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4533
star this property label Biography information for Baroness Altmann more like this
1142432
star this property registered interest false more like this
star this property date less than 2019-07-25more like thismore than 2019-07-25
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading NHS: Pensions more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what plans they have, if any, to compensate senior NHS staff who have inadvertently exceeded the tapered annual pensions allowance. more like this
star this property tabling member printed
Baroness Altmann more like this
star this property uin HL17506 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-06more like thismore than 2019-08-06
star this property answer text <p>For the majority of people, their pension contributions are tax-free. This makes pensions tax relief one of the most expensive reliefs in the personal tax system. The reforms to the lifetime and annual allowance made in the previous two parliaments are expected to save over £6 billion per year and are necessary to deliver a fair system and protect public finances. Less than 1% of pension savers will have to reduce their saving or face an annual allowance charge as a result of the tapered annual allowance.</p><p>While there are no plans to compensate senior National Health Service staff who exceed their tax-free pension savings allowances, the Scheme Pays facility is there to assist NHS Pension Scheme members who breach the annual allowance, and allows them to settle their lifetime and annual allowance charges without making an upfront payment. The Scheme Pays facility was recently extended to cover tax charges of any amount and those arising from the tapered annual allowance.</p><p>The Government has launched a full public consultation setting out proposals to make the NHS Pension Scheme more flexible for clinicians, to give them more control over their pension growth and tax liabilities.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-08-06T15:06:30.857Zmore like thismore than 2019-08-06T15:06:30.857Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4533
star this property label Biography information for Baroness Altmann more like this
1142460
star this property registered interest false more like this
star this property date less than 2019-07-25more like thismore than 2019-07-25
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Health Services and Social Services: Departmental Responsibilities more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what assessment they have made of (1) the benefits to date of bringing health and social care together in one political portfolio, and (2) the benefits that will arise in future years of bringing the two areas together. more like this
star this property tabling member printed
Baroness Neville-Rolfe more like this
star this property uin HL17534 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-07more like thismore than 2019-08-07
star this property answer text <p>The Department was renamed the Department of Health and Social Care in January 2018 and took on responsibility for the Social Care Green Paper.</p><p> </p><p>Whilst we have made no specific assessment, the Department has been working on bringing health and social care together to achieve whole-person, integrated care with the National Health Service and social care systems operating in a joined-up way. The Better Care Fund continues to drive forward the integration of health and social care in England.</p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p> more like this
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-08-07T11:44:25.723Zmore like thismore than 2019-08-07T11:44:25.723Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4284
star this property label Biography information for Baroness Neville-Rolfe more like this
1141905
star this property registered interest false more like this
star this property date less than 2019-07-24more like thismore than 2019-07-24
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Accident and Emergency Departments: Greater Manchester more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what were the average annual waiting times for each accident and emergency department in Greater Manchester in each of the last five years. more like this
star this property tabling member printed
Lord Bradley more like this
star this property uin HL17449 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-07more like thismore than 2019-08-07
star this property answer text <p>Data is not available in the format requested.</p> more like this
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-08-07T11:37:37.95Zmore like thismore than 2019-08-07T11:37:37.95Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
452
star this property label Biography information for Lord Bradley more like this
1141914
star this property registered interest false more like this
star this property date less than 2019-07-24more like thismore than 2019-07-24
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Medical Records: Data Protection more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government, in respect of its guidance Creating the right framework to realise the benefits for patients and the NHS where data underpins innovation, published on 15 July, what is meant by "fair terms" for (1) NHS organisations, and (2) the NHS as a whole. more like this
star this property tabling member printed
Lord Freyberg more like this
star this property uin HL17458 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-07more like thismore than 2019-08-07
star this property answer text <p>As set out in the recently published guidance <em>Creating the right framework to realise the benefits for patients and the NHS where data underpins innovation,</em> the Centre of Expertise will offer support to those National Health Service organisations seeking to understand whether proposed data arrangements meet the requirements set out in the five guiding principles. The Centre of Expertise will sit in NHSX. The requirement that terms are agreed which are fair to both an NHS organisation and the wider NHS, is included to ensure, for example, that local NHS trusts consider arrangements which can provide benefits to the whole NHS, not just to an individual trust. This may include a NHS trust providing access to anonymised healthcare data for development of a healthcare product in return for access at a reduced cost to that product for the whole NHS, not just that particular trust. Fair terms should ensure that benefits returned to NHS organisations and the NHS as a whole are commensurate with the outputs that are generated by the data partner. The principles are intended to apply to all NHS organisations at the primary, secondary and tertiary care levels, including national NHS organisations. However, we will consider the inclusion of arm’s length bodies as part of the next phase of work in developing a full policy framework.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN
HL17459 more like this
HL17460 more like this
star this property question first answered
less than 2019-08-07T11:38:14Zmore like thismore than 2019-08-07T11:38:14Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
2593
star this property label Biography information for Lord Freyberg more like this
1141915
star this property registered interest false more like this
star this property date less than 2019-07-24more like thismore than 2019-07-24
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Medical Records: Data Protection more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government, in respect of its guidance Creating the right framework to realise the benefits for patients and the NHS where data underpins innovation, which organisation or body will hold to account the boards of NHS organisations in ensuring that "any arrangements entered into by their organisation are fair, including recognising and safeguarding the value of the data that is shared and the resources which are generated as a result of the arrangement”. more like this
star this property tabling member printed
Lord Freyberg more like this
star this property uin HL17459 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-07more like thismore than 2019-08-07
star this property answer text <p>As set out in the recently published guidance <em>Creating the right framework to realise the benefits for patients and the NHS where data underpins innovation,</em> the Centre of Expertise will offer support to those National Health Service organisations seeking to understand whether proposed data arrangements meet the requirements set out in the five guiding principles. The Centre of Expertise will sit in NHSX. The requirement that terms are agreed which are fair to both an NHS organisation and the wider NHS, is included to ensure, for example, that local NHS trusts consider arrangements which can provide benefits to the whole NHS, not just to an individual trust. This may include a NHS trust providing access to anonymised healthcare data for development of a healthcare product in return for access at a reduced cost to that product for the whole NHS, not just that particular trust. Fair terms should ensure that benefits returned to NHS organisations and the NHS as a whole are commensurate with the outputs that are generated by the data partner. The principles are intended to apply to all NHS organisations at the primary, secondary and tertiary care levels, including national NHS organisations. However, we will consider the inclusion of arm’s length bodies as part of the next phase of work in developing a full policy framework.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN
HL17458 more like this
HL17460 more like this
star this property question first answered
less than 2019-08-07T11:38:14.047Zmore like thismore than 2019-08-07T11:38:14.047Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
2593
star this property label Biography information for Lord Freyberg more like this
1141916
star this property registered interest false more like this
star this property date less than 2019-07-24more like thismore than 2019-07-24
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Medical Records: Data Protection more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government, in respect of its guidance Creating the right framework to realise the benefits for patients and the NHS where data underpins innovation, whether, in referring to NHS organisations, national NHS organisations, pertinent departments and arms-length bodies are required not to enter into “exclusive arrangements for raw data held by them”. more like this
star this property tabling member printed
Lord Freyberg more like this
star this property uin HL17460 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-07more like thismore than 2019-08-07
star this property answer text <p>As set out in the recently published guidance <em>Creating the right framework to realise the benefits for patients and the NHS where data underpins innovation,</em> the Centre of Expertise will offer support to those National Health Service organisations seeking to understand whether proposed data arrangements meet the requirements set out in the five guiding principles. The Centre of Expertise will sit in NHSX. The requirement that terms are agreed which are fair to both an NHS organisation and the wider NHS, is included to ensure, for example, that local NHS trusts consider arrangements which can provide benefits to the whole NHS, not just to an individual trust. This may include a NHS trust providing access to anonymised healthcare data for development of a healthcare product in return for access at a reduced cost to that product for the whole NHS, not just that particular trust. Fair terms should ensure that benefits returned to NHS organisations and the NHS as a whole are commensurate with the outputs that are generated by the data partner. The principles are intended to apply to all NHS organisations at the primary, secondary and tertiary care levels, including national NHS organisations. However, we will consider the inclusion of arm’s length bodies as part of the next phase of work in developing a full policy framework.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN
HL17458 more like this
HL17459 more like this
star this property question first answered
less than 2019-08-07T11:38:14.093Zmore like thismore than 2019-08-07T11:38:14.093Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
2593
star this property label Biography information for Lord Freyberg more like this
1141919
star this property registered interest false more like this
star this property date less than 2019-07-24more like thismore than 2019-07-24
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Bacterial Diseases more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government, further to the Written Answer by Baroness Blackwood of North Oxford on 9 July (HL16592), what is their view of the proportion of each of the resulting illness, deaths and costs that could be prevented by new efforts to prevent transmission; and what are the costs of new measures introduced in 2019 to prevent transmission of carbapenem-resistant Enterobacteriaceae. more like this
star this property tabling member printed
Baroness Gardner of Parkes more like this
star this property uin HL17463 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-06more like thismore than 2019-08-06
star this property answer text <p>Public Health England (PHE) has prioritised collecting the necessary data across the National Health Service to enable estimation and monitoring of the proportion of cases, deaths and costs attributable to carbapenemase-resistant Enterobacteriaceae.</p><p>In May 2015 PHE implemented an enhanced surveillance system of all carbapenemase-producing Gram negative bacteria, which was modified in 2019 to maximise efficiency. The health burden of cases, estimated from these data, will be published in the <em>English Surveillance Programme for Antimicrobial Utilisation Report</em> in November 2019.</p><p>The few published reports of outbreaks have estimated costs of at least £1 million, and up to £5 million, all indicating multi-model control measures are required, as outlined in the PHE toolkit for prevention and control of carbapenemase-producing Enterobacteriaceae which is currently being updated.</p><p>Using national surveillance and patient administration data to develop mathematical models, work is ongoing to estimate the reduction in levels of illness and death when specified detection and control measures are applied by 2020. Developed models will enable associated costs incurred to be estimated and the cost-effectiveness of control measures to be established by 2021.</p><p> </p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-08-06T15:07:02.27Zmore like thismore than 2019-08-06T15:07:02.27Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
3596
star this property label Biography information for Baroness Gardner of Parkes more like this
1141940
star this property registered interest false more like this
star this property date less than 2019-07-24more like thismore than 2019-07-24
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Gambling: Rehabilitation more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government, further to the Written Answers by Baroness Blackwood of North Oxford on 17 July (HL16963 and HL16964), what was the budget of Leeds and York Partnership NHS Trust for funding the NHS Northern Gambling Clinic; and what is the projected cost of that clinic in (1) 2020, (2) 2021, and (3) 2022. more like this
star this property tabling member printed
The Lord Bishop of St Albans more like this
star this property uin HL17484 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-06more like thismore than 2019-08-06
star this property answer text <p>NHS England and NHS Improvement have allocated £600,000 to Central and North West London NHS Foundation Trust and £370,000 to Leeds and York Partnership NHS Foundation Trust for gambling harm services provision in 2019/20, which includes funding for these clinics.</p><p> </p><p>GambleAware, an independent charity, is providing additional funding for these clinics. Information on this funding is not held centrally.</p><p> </p><p>Future years’ funding is not yet available.</p><p> </p><p> </p> more like this
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN HL17485 more like this
star this property question first answered
less than 2019-08-06T14:58:10.86Zmore like thismore than 2019-08-06T14:58:10.86Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4308
star this property label Biography information for The Lord Bishop of St Albans more like this
1141941
star this property registered interest false more like this
star this property date less than 2019-07-24more like thismore than 2019-07-24
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading National Problem Gambling Clinic more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government, further to the Written Answers by Baroness Blackwood of North Oxford on 17 July (HL16963 and HL16964), what was the budget of the Central and North West London NHS Foundation Trust for funding the National Problem Gambling Clinic; and what is the projected cost of that clinic in (1) 2020, (2) 2021, and (3) 2022. more like this
star this property tabling member printed
The Lord Bishop of St Albans more like this
star this property uin HL17485 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-06more like thismore than 2019-08-06
star this property answer text <p>NHS England and NHS Improvement have allocated £600,000 to Central and North West London NHS Foundation Trust and £370,000 to Leeds and York Partnership NHS Foundation Trust for gambling harm services provision in 2019/20, which includes funding for these clinics.</p><p> </p><p>GambleAware, an independent charity, is providing additional funding for these clinics. Information on this funding is not held centrally.</p><p> </p><p>Future years’ funding is not yet available.</p><p> </p><p> </p> more like this
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN HL17484 more like this
star this property question first answered
less than 2019-08-06T14:58:10.893Zmore like thismore than 2019-08-06T14:58:10.893Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4308
star this property label Biography information for The Lord Bishop of St Albans more like this
1141956
star this property registered interest false more like this
star this property date less than 2019-07-24more like thismore than 2019-07-24
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Children: Mental Illness more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what assessment they have made of reports that referrals to child mental health units from primary schools for pupils aged 11 and under have risen by almost 50 per cent in the last three years. more like this
star this property tabling member printed
Lord Watson of Invergowrie more like this
star this property uin HL17500 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-07more like thismore than 2019-08-07
star this property answer text <p>No formal assessment has been made as comparable data is not available at a national level.</p><p>Referral data for children and young people’s mental health services is published by NHS Digital in the Mental Health Services Dataset since 2017. This shows that in 2017/18 there were 259,615 new referrals to children and young people’s mental health services for people aged 0-18 and 381,528 new referrals for the same in 2018/19.</p><p>The number of providers supplying data has increased in 2018/19 and so a direct comparison between the two years is not possible.</p> more like this
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-08-07T11:38:28.227Zmore like thismore than 2019-08-07T11:38:28.227Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
1241
star this property label Biography information for Lord Watson of Invergowrie more like this
1141957
star this property registered interest false more like this
star this property date less than 2019-07-24more like thismore than 2019-07-24
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Breast Cancer: Drugs more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what are the drugs approved by NICE to treat HER2+ breast cancer; and what assessment they have made of the efficacy of such drugs. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL17501 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-25more like thismore than 2019-07-25
star this property answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body responsible for making recommendations for the National Health Service on whether drugs and other treatments represent a clinically and cost effective use of NHS resources.</p><p>NICE has recommended the following drugs for the treatment of HER2-positive breast cancer: trastuzumab emtansine (Kadcyla) for treating HER2-positive advanced breast cancer after trastuzumab (Herceptin) and a taxane; pertuzumab (Perjeta) with trastuzumab (Herceptin) and docetaxel for treating HER2-positive breast cancer; pertuzumab (Perjeta) for the neoadjuvant treatment of HER2-positive breast cancer; and pertuzumab (Perjeta) for adjuvant treatment of HER2-positive early stage breast cancer.</p><p>NHS commissioners are legally required to fund drugs recommended in NICE technology appraisal guidance. It is for clinicians to decide on the most appropriate treatment for an individual patient based on their clinical judgement and in discussion with the patient.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN HL17502 more like this
star this property question first answered
less than 2019-07-25T16:45:03.16Zmore like thismore than 2019-07-25T16:45:03.16Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4151
star this property label Biography information for Lord Willis of Knaresborough more like this
1141958
star this property registered interest false more like this
star this property date less than 2019-07-24more like thismore than 2019-07-24
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Pertuzumab more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what advice they provide to clinicians for the use of Pertuzumab rather than Herceptin for the treatment of HER2+ breast cancer. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL17502 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-25more like thismore than 2019-07-25
star this property answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body responsible for making recommendations for the National Health Service on whether drugs and other treatments represent a clinically and cost effective use of NHS resources.</p><p>NICE has recommended the following drugs for the treatment of HER2-positive breast cancer: trastuzumab emtansine (Kadcyla) for treating HER2-positive advanced breast cancer after trastuzumab (Herceptin) and a taxane; pertuzumab (Perjeta) with trastuzumab (Herceptin) and docetaxel for treating HER2-positive breast cancer; pertuzumab (Perjeta) for the neoadjuvant treatment of HER2-positive breast cancer; and pertuzumab (Perjeta) for adjuvant treatment of HER2-positive early stage breast cancer.</p><p>NHS commissioners are legally required to fund drugs recommended in NICE technology appraisal guidance. It is for clinicians to decide on the most appropriate treatment for an individual patient based on their clinical judgement and in discussion with the patient.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN HL17501 more like this
star this property question first answered
less than 2019-07-25T16:45:03.207Zmore like thismore than 2019-07-25T16:45:03.207Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4151
star this property label Biography information for Lord Willis of Knaresborough more like this
1141959
star this property registered interest false more like this
star this property date less than 2019-07-24more like thismore than 2019-07-24
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Breast Cancer: Clinical Trials more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government which clinical trials are currently recruiting patients with HER2+ breast cancer. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL17503 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-07more like thismore than 2019-08-07
star this property answer text <p>The Department’s National Institute for Health Research (NIHR) is currently recruiting to 15 clinical trials for people with HER2+ breast cancer via its Clinical Research Network. The majority of these are commercially funded. To date, a total of 7,986 participants have been recruited to these 15 trials.</p><p>Of the 15 clinical trials, 12 are commercially sensitive, with appropriate cost recovery from the companies. The data for these commercial trials has been provided from the relevant companies as ‘commercial in confidence’ hence we are unable to provide details about these trials such as their titles.</p><p>However, the three clinical trials which are not commercially sensitive are:</p><p>- Cancer Research UK; NIHR Evaluation, Trials and Studies Co-ordinating Centre (NETSCC). Title: The UK plasma based Molecular profiling of Advanced breast cancer to inform Therapeutic Choices (plasmaMATCH);</p><p>- Cancer Research UK. Title: Response to Optimal Selection of neo-adjuvant Chemotherapy in Operable breast cancer; and</p><p>- Medical Research Council. Title: A mechanistic non-invasive imaging study of HER2 expression in breast cancer using [18F]GE-226 positron emission tomography.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-08-07T11:43:14.327Zmore like thismore than 2019-08-07T11:43:14.327Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4151
star this property label Biography information for Lord Willis of Knaresborough more like this
1141251
star this property registered interest false more like this
star this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Cancer: Health Services more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, when a long-term workforce plan which sets out the number of staff required to meet the current and future needs of cancer patients will be published. more like this
star this property tabling member constituency Denton and Reddish more like this
star this property tabling member printed
Andrew Gwynne more like this
star this property uin 280964 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-05more like thismore than 2019-08-05
star this property answer text <p>The interim NHS People Plan, published on 3 June 2019, puts the workforce at the heart of the National Health Service and will ensure we have the staff needed to deliver high quality care. A final People Plan will be published soon after the conclusion of the 2019 Spending Review.</p><p>Phase 1 of the Cancer Workforce Plan for England, published in December 2017 by Health Education England (HEE), set out plans to expand capacity and skills in the cancer workforce, including targeting additional training support for seven priority professions which are key to cancer prevention, diagnosis and treatment, such as clinical radiology, histopathology, oncology and diagnostic and therapeutic radiography.</p><p>HEE will now work with NHS England and NHS Improvement to understand the longer-term workforce implications of further development of cancer services. This work will inform the final People Plan.</p> more like this
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property question first answered
less than 2019-08-05T11:30:43.603Zmore like thismore than 2019-08-05T11:30:43.603Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
1506
star this property label Biography information for Andrew Gwynne more like this
1141253
star this property registered interest false more like this
star this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential effect of the UK leaving the EU on the supply of drugs to the NHS. more like this
star this property tabling member constituency Tooting more like this
star this property tabling member printed
Dr Rosena Allin-Khan more like this
star this property uin 281022 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-02more like thismore than 2019-08-02
star this property answer text <p>The United Kingdom will leave the European Union on 31 October, with or without a deal. The Government would prefer the UK to leave the EU with a deal and, in the event that the UK leaves the EU with a new deal, the Department’s assessment is that access to medicines and medical devices will not change for industry or the National Health Service.</p><p>While the Prime Minister is confident that he can strike a new arrangement with the EU, it is vital that we prepare for a ‘no deal’ outcome. Therefore, as a responsible Government, we continue to take steps to ensure the supply of medicines and medical products is uninterrupted in a ‘no deal’ scenario.</p><p>On 26 June, we wrote to suppliers of medicines to the UK from or via the EU or European Economic Area setting out our continuing multi-layered approach to ensure the continuity of supply of all medicines and medical products in a potential ‘no deal’ exit scenario on 31 October.</p><p>Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>Ahead of 31 October, all necessary funding will be made available to support our ‘no deal’ preparations. On 1 August, Her Majesty’s Treasury announced an additional £434 million made available to help ensure continuity of supply of vital medicines and medical products, including through freight capacity, warehousing and stockpiling.</p><p>We are confident that the Department is doing everything appropriate to prepare for a possible ‘no deal’ EU exit on 31 October. We are working with our partners, including suppliers, freight companies and the health and social care system and our plans should ensure the supply of medicines and medical products remains uninterrupted.</p>
star this property answering member constituency Kingswood more like this
star this property answering member printed Chris Skidmore more like this
star this property question first answered
less than 2019-08-02T09:59:35.05Zmore like thismore than 2019-08-02T09:59:35.05Z
star this property answering member
4021
star this property label Biography information for Chris Skidmore more like this
star this property tabling member
4573
star this property label Biography information for Dr Rosena Allin-Khan more like this
1141255
star this property registered interest false more like this
star this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Non-surgical Cosmetic Procedures: Children more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what legal duties govern the administering of dermal fillers to people under the age of 18 by non-regulated practitioners. more like this
star this property tabling member constituency North Durham more like this
star this property tabling member printed
Mr Kevan Jones more like this
star this property uin 280927 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-25more like thismore than 2019-07-25
star this property answer text <p>Currently there are no restrictions that limit the administration of dermal fillers on young people under the age of 18 years old.</p><p>The Department is exploring options to introduce age restrictions on access to cosmetic procedures, bringing them in line with legislation on tattoos, teeth whitening and the use of sunbeds. From May 2020 all dermal fillers, irrespective of their composition and intended use, will be regulated as medical devices under Annex XVI of the Medical Device Regulations (EU 2017/745). The new Regulations will significantly improve the quality and safety of dermal fillers.</p><p>The Government is committed to improving the safety of cosmetic procedures through better training for practitioners, and clear information so that people can make informed decisions about their care. The growth in non-surgical treatments increases the need for consumer protection and we are currently working with stakeholders to strengthen the regulation of cosmetic procedures.</p><p>We urge anyone seeking a cosmetic procedure to take the time to find a reputable, insured and appropriately qualified practitioner who is either subject to statutory regulation or on a voluntary register accredited by the Professional Standards Authority.</p>
star this property answering member constituency Thurrock more like this
star this property answering member printed Jackie Doyle-Price more like this
star this property question first answered
less than 2019-07-25T16:32:36.833Zmore like thismore than 2019-07-25T16:32:36.833Z
star this property answering member
4065
star this property label Biography information for Jackie Doyle-Price more like this
star this property tabling member
1438
star this property label Biography information for Mr Kevan Jones more like this
1141282
star this property registered interest false more like this
star this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Electronic Cigarettes: Health Hazards more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the increased numbers of people vaping on (a) nicotine addiction, (b) incidences of increased blood pressure and (c) heart attack rates. more like this
star this property tabling member constituency North East Hampshire more like this
star this property tabling member printed
Mr Ranil Jayawardena more like this
star this property uin 281030 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-05more like thismore than 2019-08-05
star this property answer text <p>Public Health England (PHE) has published a series of reports on electronic cigarettes including the effects of vaping on health. The reports are available to view at the following link:</p><p><a href="https://www.gov.uk/government/collections/e-cigarettes-and-vaping-policy-regulation-and-guidance" target="_blank">https://www.gov.uk/government/collections/e-cigarettes-and-vaping-policy-regulation-and-guidance</a></p><p>While nicotine can contribute to raised blood pressure and cardiovascular risk, it is tar and carbon monoxide, which are the major sources of cardiovascular risk in cigarette smoke, producing nicotine vapour from a solution rather than by burning tobacco means that electronic cigarette vapour is free from almost all the toxic chemicals that accompany nicotine in cigarette smoke.</p><p>The Office for National Statistics has recorded the numbers of people using e-cigarettes since 2014 and the combined number of people using e-cigarettes and smoking has not increased since then. The proportion of people who smoke has decreased substantially in the same period.</p><p>PHE encourages people who both vape and smoke to stop smoking completely, because this greatly reduces health risks.</p><p><strong> </strong></p><p><strong> </strong></p>
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property question first answered
less than 2019-08-05T11:25:52.907Zmore like thismore than 2019-08-05T11:25:52.907Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
4498
star this property label Biography information for Mr Ranil Jayawardena more like this
1141283
star this property registered interest false more like this
star this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Electronic Cigarettes more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will bring forward legislative proposals to ban e-cigarettes wherever the smoking ban is in place. . more like this
star this property tabling member constituency North East Hampshire more like this
star this property tabling member printed
Mr Ranil Jayawardena more like this
star this property uin 281031 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-05more like thismore than 2019-08-05
star this property answer text <p>The Government believes in proportionate regulation of e-cigarettes, recognising that they are not risk-free. Through the European Union Tobacco Products Directive 2014/40/EU (TPD), transposed into United Kingdom law by the UK Tobacco and Related Products Regulations 2016 (TRPR), we have introduced measures to regulate e-cigarettes. These measures reduce the risk of harm to children, protect against any risk of renormalisation of tobacco use, provide assurance on relative safety for users, and give businesses legal certainty. This has enabled the UK to implement appropriate standards for products whilst allowing smokers to move to e-cigarettes should they wish.</p><p> </p><p>The Government has made a commitment to review the TRPR by May 2021 to consider its regulatory impact. In addition, as announced in the Tobacco Control Plan the Government will review where the UK’s exit from the European Union offers us opportunities to re-appraise current regulation to ensure this continues to protect the nation’s health.</p><p>The Government has no plans to introduce legislative proposals to ban e-cigarettes, e-cigarette shops or smoking on National Health Service property.</p><p>We continue to support the implementation of smokefree policies across all hospitals in England. The Government’s tobacco control plan for England published in July 2017 reiterates our ambition to achieve smokefree mental health services and NHS estate by 2019/20. The NHS Long Term Plan, published in January 2019, further supports the creation of a Smokefree NHS with the commitment to offering NHS-funded tobacco treatment services to all patients who smoke.</p>
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property grouped question UIN 281032 more like this
star this property question first answered
less than 2019-08-05T11:29:19.74Zmore like thismore than 2019-08-05T11:29:19.74Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
4498
star this property label Biography information for Mr Ranil Jayawardena more like this
1141284
star this property registered interest false more like this
star this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Hospitals: Electronic Cigarettes more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will bring forward legislative proposals to ban (a) e-cigarette shops and (b) smoking on NHS hospital property. more like this
star this property tabling member constituency North East Hampshire more like this
star this property tabling member printed
Mr Ranil Jayawardena more like this
star this property uin 281032 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-05more like thismore than 2019-08-05
star this property answer text <p>The Government believes in proportionate regulation of e-cigarettes, recognising that they are not risk-free. Through the European Union Tobacco Products Directive 2014/40/EU (TPD), transposed into United Kingdom law by the UK Tobacco and Related Products Regulations 2016 (TRPR), we have introduced measures to regulate e-cigarettes. These measures reduce the risk of harm to children, protect against any risk of renormalisation of tobacco use, provide assurance on relative safety for users, and give businesses legal certainty. This has enabled the UK to implement appropriate standards for products whilst allowing smokers to move to e-cigarettes should they wish.</p><p> </p><p>The Government has made a commitment to review the TRPR by May 2021 to consider its regulatory impact. In addition, as announced in the Tobacco Control Plan the Government will review where the UK’s exit from the European Union offers us opportunities to re-appraise current regulation to ensure this continues to protect the nation’s health.</p><p>The Government has no plans to introduce legislative proposals to ban e-cigarettes, e-cigarette shops or smoking on National Health Service property.</p><p>We continue to support the implementation of smokefree policies across all hospitals in England. The Government’s tobacco control plan for England published in July 2017 reiterates our ambition to achieve smokefree mental health services and NHS estate by 2019/20. The NHS Long Term Plan, published in January 2019, further supports the creation of a Smokefree NHS with the commitment to offering NHS-funded tobacco treatment services to all patients who smoke.</p>
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property grouped question UIN 281031 more like this
star this property question first answered
less than 2019-08-05T11:29:19.787Zmore like thismore than 2019-08-05T11:29:19.787Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
4498
star this property label Biography information for Mr Ranil Jayawardena more like this
1141336
star this property registered interest false more like this
star this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Pharmacy more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the number of community pharmacies. more like this
star this property tabling member constituency Harborough more like this
star this property tabling member printed
Neil O'Brien more like this
star this property uin 281058 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-05more like thismore than 2019-08-05
star this property answer text <p>The Government is not actively looking to increase the number of community pharmacies in England.</p><p>Applications to provide National Health Service pharmaceutical services continue to be determined by NHS England and NHS Improvement, informed by the local pharmaceutical needs assessment, which outlines the level of NHS pharmaceutical services provision in a given area, including if there are any gaps or unmet needs.</p><p>In England, access to NHS pharmaceutical services is good. There are over 11,500 community pharmacies, which is 12% more than a decade ago. This coverage means that 80% of the population live within 20 minutes walking distance of a community pharmacy, with more pharmacies in the most deprived areas.</p><p>Maintaining access to NHS pharmaceutical services remains an important priority for the Government. We will continue to maintain the good level of access we have in England through the Pharmacy Access Scheme, which provides additional financial support to pharmacies in areas where there are fewer pharmacies.</p>
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property question first answered
less than 2019-08-05T11:27:19.42Zmore like thismore than 2019-08-05T11:27:19.42Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
4679
star this property label Biography information for Neil O'Brien more like this
1141356
star this property registered interest false more like this
star this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Sapropterin more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment his Department has made of whether Kuvan should be assessed through NICE's highly-specialised technology appraisal. more like this
star this property tabling member constituency North Durham more like this
star this property tabling member printed
Mr Kevan Jones more like this
star this property uin 280943 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-06more like thismore than 2019-08-06
star this property answer text <p>Decisions on whether individual medicines are suitable for assessment by the National Institute for Health and Care Excellence (NICE), and whether they meet the criteria for the highly specialised technologies programme, are taken through an established topic selection process.</p><p>The process is overseen by NICE and includes consideration against published criteria by a topic selection panel and engagement with stakeholders. Although NHS England, NHS Improvement and the Department provide input and are part of this panel, the decision-making process is led by NICE. Kuvan for the treatment of phenylketonuria was last considered by the topic selection panel on 15 February 2019.</p><p>In the absence of guidance from NICE, it is for National Health Service organisations and healthcare professionals to make decisions on whether to fund Kuvan on the basis of an assessment of the available evidence. Treatment for patients with phenylketonuria who are not receiving Kuvan or for who Kuvan is not effective includes dietary protein restriction combined with dietary supplements.</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p>
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property question first answered
less than 2019-08-06T14:36:02.507Zmore like thismore than 2019-08-06T14:36:02.507Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
1438
star this property label Biography information for Mr Kevan Jones more like this
1141362
star this property registered interest false more like this
star this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Measles more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what guidance his Department has published on distinguishing between rashes caused by the measles vaccine and those arising from the wild strain of measles. more like this
star this property tabling member constituency Gravesham more like this
star this property tabling member printed
Adam Holloway more like this
star this property uin 280995 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-05more like thismore than 2019-08-05
star this property answer text <p>While post vaccine rash and fever is generally mild, distinguishing from wild-type measles is not based on clinical examination, rather it is based on a combination of laboratory analysis, information on the timing of vaccine and epidemiological information. The national measles guidelines describe the management and investigation of suspected cases of measles, and is available to view at the following link:</p><p><a href="https://www.gov.uk/government/publications/national-measles-guidelines" target="_blank">https://www.gov.uk/government/publications/national-measles-guidelines</a></p><p>Statistics on confirmed measles cases are reported by vaccination status and are available at the following link:</p><p><a href="https://www.gov.uk/government/publications/measles-mumps-and-rubella-lab-confirmed-cases-in-england-2019" target="_blank">https://www.gov.uk/government/publications/measles-mumps-and-rubella-lab-confirmed-cases-in-england-2019</a></p><p> </p><p> </p> more like this
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property grouped question UIN 280996 more like this
star this property question first answered
less than 2019-08-05T11:32:33.127Zmore like thismore than 2019-08-05T11:32:33.127Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
1522
star this property label Biography information for Adam Holloway more like this
1141363
star this property registered interest false more like this
star this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Measles more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that statistics on the infection rate for measles do not include people who have received the live measles vaccine and contracted a measles-like rash and fever. more like this
star this property tabling member constituency Gravesham more like this
star this property tabling member printed
Adam Holloway more like this
star this property uin 280996 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-05more like thismore than 2019-08-05
star this property answer text <p>While post vaccine rash and fever is generally mild, distinguishing from wild-type measles is not based on clinical examination, rather it is based on a combination of laboratory analysis, information on the timing of vaccine and epidemiological information. The national measles guidelines describe the management and investigation of suspected cases of measles, and is available to view at the following link:</p><p><a href="https://www.gov.uk/government/publications/national-measles-guidelines" target="_blank">https://www.gov.uk/government/publications/national-measles-guidelines</a></p><p>Statistics on confirmed measles cases are reported by vaccination status and are available at the following link:</p><p><a href="https://www.gov.uk/government/publications/measles-mumps-and-rubella-lab-confirmed-cases-in-england-2019" target="_blank">https://www.gov.uk/government/publications/measles-mumps-and-rubella-lab-confirmed-cases-in-england-2019</a></p><p> </p><p> </p> more like this
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property grouped question UIN 280995 more like this
star this property question first answered
less than 2019-08-05T11:32:33.183Zmore like thismore than 2019-08-05T11:32:33.183Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
1522
star this property label Biography information for Adam Holloway more like this
1141364
star this property registered interest false more like this
star this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading MMR Vaccine: Side Effects more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that (a) body inclusion encephalitis and (b) other adverse events experienced after a measles vaccine are identified in a timely way by healthcare professionals. more like this
star this property tabling member constituency Gravesham more like this
star this property tabling member printed
Adam Holloway more like this
star this property uin 280997 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-08-05more like thismore than 2019-08-05
star this property answer text <p>The safety of all the United Kingdom’s vaccination programmes is of paramount importance. Any serious side effects are extremely rare, and the large majority of side effects are mild and transient, such as sore arms, headaches and tiredness. We would recommend that all eligible children are vaccinated, as any potential risk of side effects is far outweighed by the benefits of vaccination.</p><p>Healthcare professionals have access to a range of materials, such as ‘Immunisation against infectious disease: the green book’ and Patient Group Directions to support their decision-making in the case of any suspected adverse effects.</p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) operates the ‘Yellow Card Scheme’, which is vital in helping the MHRA monitor the safety of all healthcare products in the UK. This system allows for reporting of any potential adverse events for all medicines, including vaccines, with guidance for healthcare professionals, patients and the public on how to use the scheme.</p><p>In addition, Public Health England (PHE) offers diagnostic services for suspected cases of encephalitis, which is a notifiable condition. Under statutory duty, cases must be reported by healthcare professionals to PHE’s local Health Protection Teams. This can be viewed at the following link:</p><p><a href="https://www.gov.uk/government/collections/notifications-of-infectious-diseases-noids" target="_blank">https://www.gov.uk/government/collections/notifications-of-infectious-diseases-noids</a></p>
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property question first answered
less than 2019-08-05T11:34:01.177Zmore like thismore than 2019-08-05T11:34:01.177Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
1522
star this property label Biography information for Adam Holloway more like this